Hilltop Holdings Inc. Sells 5,366 Shares of Danaher Corporation $DHR

Hilltop Holdings Inc. lowered its position in shares of Danaher Corporation (NYSE:DHR) by 52.9% in the first quarter, Holdings Channel reports. The institutional investor owned 4,772 shares of the conglomerate’s stock after selling 5,366 shares during the period. Hilltop Holdings Inc.’s holdings in Danaher were worth $905,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of DHR. Main Street Group LTD acquired a new stake in Danaher in the 1st quarter worth about $25,000. JPL Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC acquired a new position in shares of Danaher during the 4th quarter worth approximately $26,000. WFA of San Diego LLC bought a new position in shares of Danaher during the second quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Up 0.2%

Shares of DHR stock opened at $191.87 on Monday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock’s fifty day moving average price is $185.64 and its two-hundred day moving average price is $196.76. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a market cap of $134.88 billion, a PE ratio of 34.08, a P/E/G ratio of 2.38 and a beta of 0.79.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the prior year, the company earned $0.77 EPS. Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. Equities analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s payout ratio is 28.42%.

Analysts Set New Price Targets

DHR has been the topic of a number of recent research reports. TD Cowen lowered their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday. Guggenheim reduced their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday. Barclays decreased their price target on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Finally, Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Key Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: J.P. Morgan reiterated a Buy rating on Danaher, which may help support investor confidence after the post-earnings pullback. J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
• Positive Sentiment: Several articles argue Danaher’s recent slump looks like an overreaction and could be a buying opportunity, suggesting the stock may recover if investors refocus on its long-term fundamentals. Here’s Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
• Positive Sentiment: Danaher’s quarterly results beat estimates, with EPS of $1.94 versus $1.85 expected and revenue of $6.27 billion above forecasts, which supports the case that core business performance remains solid. The ‘Standout Performance’ That Could Save Thermo Fisher, Danaher And Others
• Neutral Sentiment: Billionaire investor Dan Loeb reduced his Danaher stake in Q1 2026, adding to sentiment pressure around life sciences tools stocks, though it does not change Danaher’s operating results. Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
• Neutral Sentiment: Danaher saw unusually heavy put option activity, signaling traders are hedging against more downside in the near term. Don’t Quit on Danaher Stock After Horrific Earnings Reaction

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.